Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AMO Deciding Whether To Enter Contact Lens, Dry Eye Markets

This article was originally published in The Gray Sheet

Executive Summary

Advanced Medical Optics will decide this year if it will make a long-term commitment in the contact lens sector

You may also be interested in...



AMO chases contacts after Visx merger

Advanced Medical Optics will seek acquisitions in contact lens arena - potentially competing with giants Ciba Vision, Bausch & Lomb and J&J/Vistakon. AMO inked a July pact to market CooperVision's hydrogel contact lenses in Europe and the Asia-Pacific under its Complete eye care line, with the lenses branded as Aquavision. The licensing deal allows AMO to test the waters "before we jump in," Mazzo says at First Albany Capital analyst conference Dec. 7. The firm expects its $1.27 bil. acquisition of Visx to close in Q1 2005...

Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables

Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT021543

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel